Darwish, S.S.; Chen, P.-J.; Hamed, M.M.; Wagdy, R.A.; Chen, S.-H.; Abadi, A.H.; Abdel-Halim, M.; Hwang, T.-L.; Engel, M.
Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors. Pharmaceuticals 2022, 15, 778.
https://doi.org/10.3390/ph15070778
AMA Style
Darwish SS, Chen P-J, Hamed MM, Wagdy RA, Chen S-H, Abadi AH, Abdel-Halim M, Hwang T-L, Engel M.
Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors. Pharmaceuticals. 2022; 15(7):778.
https://doi.org/10.3390/ph15070778
Chicago/Turabian Style
Darwish, Sarah S., Po-Jen Chen, Mostafa M. Hamed, Reem A. Wagdy, Shun-Hua Chen, Ashraf H. Abadi, Mohammad Abdel-Halim, Tsong-Long Hwang, and Matthias Engel.
2022. "Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors" Pharmaceuticals 15, no. 7: 778.
https://doi.org/10.3390/ph15070778
APA Style
Darwish, S. S., Chen, P.-J., Hamed, M. M., Wagdy, R. A., Chen, S.-H., Abadi, A. H., Abdel-Halim, M., Hwang, T.-L., & Engel, M.
(2022). Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors. Pharmaceuticals, 15(7), 778.
https://doi.org/10.3390/ph15070778